Pulmonx
Stefanie G. is a seasoned professional in product management and marketing within the healthcare sector, with a focus on urology and pelvic floor therapies. Currently serving as Product Manager DACH at Pulmonx Corporation since July 2022, Stefanie previously held the position of Global Head of Marketing & Product Management for Urology at Medi-Globe Corporation from April 2019 to May 2022. Stefanie's extensive experience also includes roles at Medtronic, where responsibilities included Therapy Development Manager for Pelvic Floor Management and Pain Therapies, and product management positions at Aesculap AG & Co. KG and B. Braun Surgical S.A. Educational background includes a Master of Science in Health Economics, Policy and Management from The London School of Economics and Political Science, as well as qualifications in pharmaceutical referral and business management.
This person is not in the org chart
This person is not in any offices
Pulmonx
2 followers
Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced. Reducing hyperinflation allows the healthier parts of the lungs to expand and take in more air. This results in patients being able to breathe easier and have less shortness of breath.1